MIZUHO MEDY CO.,LTD. Logo

MIZUHO MEDY CO.,LTD.

Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.

4595 | T

Overview

Corporate Details

ISIN(s):
JP3885900005
LEI:
Country:
Japan
Address:
鳥栖市藤木町5番地の4
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Mizuho Medy Co., Ltd. is an in vitro diagnostics (IVD) company that specializes in the research, development, manufacturing, and sale of diagnostic products. The company's portfolio focuses on rapid immunoassay and nucleic acid amplification technologies, with a significant emphasis on point-of-care testing (POCT) reagents. Its product lines include the 'Quick Chaser' series for detecting infectious diseases like influenza, RSV, and SARS-CoV-2, and the 'Quick Checker' series for hormonal tests such as pregnancy and ovulation. In addition to diagnostic kits, Mizuho Medy develops instruments like fully automated gene analyzers. The company serves the clinical, research, and agricultural markets and operates under the ISO 13485 quality management standard for medical devices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 06:06
Interim Report
確認書
Japanese 8.7 KB
2025-08-08 06:04
Interim Report
半期報告書-第49期(2025/01/01-2025/12/31)
Japanese 204.8 KB
2025-04-02 06:17
Post-Annual General Meeting Information
臨時報告書
Japanese 25.9 KB
2025-03-31 03:44
Governance Information
内部統制報告書-第48期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-31 03:41
Registration Form
確認書
Japanese 8.7 KB
2025-03-31 03:37
Annual Report
有価証券報告書-第48期(2024/01/01-2024/12/31)
Japanese 931.6 KB
2024-08-09 06:11
Regulatory News Service
確認書
Japanese 8.7 KB
2024-08-09 06:09
Interim Report
半期報告書-第48期(2024/01/01-2024/12/31)
Japanese 209.8 KB
2024-05-10 06:07
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-05-10 06:06
Quarterly Report
四半期報告書-第48期第1四半期(2024/01/01-2024/03/31)
Japanese 169.5 KB
2024-04-01 09:48
Post-Annual General Meeting Information
臨時報告書
Japanese 21.6 KB
2024-03-29 02:02
Governance Information
内部統制報告書-第47期(2023/01/01-2023/12/31)
Japanese 22.5 KB
2024-03-29 01:59
Registration Form
確認書
Japanese 8.7 KB
2024-03-29 01:56
Annual Report
有価証券報告書-第47期(2023/01/01-2023/12/31)
Japanese 967.0 KB
2023-11-10 05:09
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all MIZUHO MEDY CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MIZUHO MEDY CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MIZUHO MEDY CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Assertio Holdings, Inc. Logo
Offers branded prescription drugs for neurology, pain, and CNS to US patients.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan
4503
Astena Holdings Co., Ltd. Logo
Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.
Japan
8095
AstraZeneca PLC Logo
Global biopharma developing medicines for oncology, cardiovascular, respiratory & rare diseases.
United Kingdom
AZN
Astria Therapeutics, Inc. Logo
Developing long-acting therapies for rare allergic and immunologic diseases like HAE.
United States of America
ATXS
ATAI Life Sciences N.V. Logo
Clinical-stage biopharma creating novel psychedelic drugs for mental health disorders.
United States of America
ATAI
Atara Biotherapeutics, Inc. Logo
Pioneering off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.
United States of America
ATRA
Atea Pharmaceuticals, Inc. Logo
A clinical-stage biopharma developing oral antiviral therapies for viruses like Hepatitis C.
United States of America
AVIR
Athira Pharma, Inc. Logo
Developing small-molecule therapies to slow neurodegeneration in diseases like Alzheimer's.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing (Z)-endoxifen for breast cancer treatment and prevention.
United States of America
ATOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.